ARQT Competitors & Alternatives
Compare Arcutis Biotherapeutics Inc with similar stocks in the same industry
Biotechnology
ARQT
Main Stock$26.27
Tradestie Score
56
Market Cap
$2.37B
Revenue Growth
0.6%
Analyst Upside
+31.8%
Top Competitors
226 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
ADMA
ADMA Biologics, Inc.
|
$8.69
|
$3.59B | 12.6 | 62 | Compare |
|
ACAD
Acadia Pharmaceuticals Inc.
|
$22.60
|
$3.58B | 10.0 | 65 | Compare |
|
LGND
Ligand Pharmaceuticals Inc.
|
$279.44
|
$3.49B | 34.1 | 64 | Compare |
|
TLX
Telix Pharmaceuticals Limited American Depositary Shares
|
$10.21
|
$3.40B | - | 55 | Compare |
|
QURE
uniQure N.V.
|
$49.04
|
$3.39B | - | 63 | Compare |
|
SRRK
Scholar Rock Holding Corporation Common Stock
|
$51.27
|
$3.33B | - | 62 | Compare |
|
NAMS
NewAmsterdam Pharma Company N.V. Ordinary Shares
|
$31.40
|
$3.31B | - | 50 | Compare |
|
SLNO
Soleno Therapeutics, Inc. Common Stock
|
$53.01
|
$3.20B | 27.5 | 49 | Compare |
|
MLYS
Mineralys Therapeutics, Inc. Common Stock
|
$25.61
|
$3.09B | - | 54 | Compare |
|
VKTX
Viking Therapeutics, Inc
|
$34.81
|
$3.08B | - | 65 | Compare |
More ARQT Analysis
Data updated: Jun 23, 2026 | Industry: Biotechnology (SIC 2834)
226 stocks in this industry